The BioWorld Emerging Biotech Index is our third market indicator and now joins the Blue Chip Index and Growth Index that were launched last week. This new metric will closely follow small-cap companies that have market caps averaging about $500 million. It is a diverse group, with some companies in the group following a business model that embraces innovation as well as in-licensing products that are market-ready. Many have lead products in early or mid-stage development. Read More
While some genes have been linked to autism spectrum disorder, the exact cause of the disease isn’t known. With a dearth of knowledge about the disease, there haven’t been any drugs specifically developed to treat autism, although Risperdal (risperidone, Johnson & Johnson) and Abilify (aripiprazole, Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. Ltd) are approved to treat irritability associated with autism. Read More
